Bo Pang

2.1k total citations
62 papers, 1.4k citations indexed

About

Bo Pang is a scholar working on Complementary and alternative medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Bo Pang has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Complementary and alternative medicine, 17 papers in Infectious Diseases and 10 papers in Molecular Biology. Recurrent topics in Bo Pang's work include Traditional Chinese Medicine Studies (12 papers), Viral Infections and Vectors (9 papers) and Acupuncture Treatment Research Studies (7 papers). Bo Pang is often cited by papers focused on Traditional Chinese Medicine Studies (12 papers), Viral Infections and Vectors (9 papers) and Acupuncture Treatment Research Studies (7 papers). Bo Pang collaborates with scholars based in China, United States and Hong Kong. Bo Pang's co-authors include David Zhang, Peter C. Dedon, José L. McFaline‐Figueroa, Ke Wang, David B. Schauer, Barry Rickman, Catherine A. Moroski-Erkul, James M. Bugni, Chung‐Wei Lee and Diana Borenshtein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Bo Pang

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Pang China 14 514 355 182 164 156 62 1.4k
Pei Zhang China 19 389 0.8× 76 0.2× 135 0.7× 107 0.7× 127 0.8× 112 1.4k
Mengyang Liu China 28 793 1.5× 172 0.5× 137 0.8× 178 1.1× 295 1.9× 107 2.2k
Miaomiao Wang China 25 542 1.1× 70 0.2× 153 0.8× 212 1.3× 172 1.1× 124 1.6k
Ren‐Jun Hsu Taiwan 23 531 1.0× 75 0.2× 255 1.4× 164 1.0× 78 0.5× 74 1.5k
Shuyuan Li China 21 575 1.1× 48 0.1× 157 0.9× 104 0.6× 103 0.7× 89 1.3k
Yin Yin China 29 860 1.7× 81 0.2× 546 3.0× 269 1.6× 302 1.9× 86 2.4k
Bidhan Chandra Koner India 27 381 0.7× 76 0.2× 188 1.0× 120 0.7× 131 0.8× 122 2.1k
Xiong Chen China 24 1.1k 2.1× 67 0.2× 385 2.1× 160 1.0× 129 0.8× 102 1.8k
Qi Dai China 26 783 1.5× 119 0.3× 225 1.2× 498 3.0× 79 0.5× 91 2.7k
Shangjie Wu China 16 666 1.3× 39 0.1× 243 1.3× 121 0.7× 138 0.9× 56 1.8k

Countries citing papers authored by Bo Pang

Since Specialization
Citations

This map shows the geographic impact of Bo Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Pang more than expected).

Fields of papers citing papers by Bo Pang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Pang. The network helps show where Bo Pang may publish in the future.

Co-authorship network of co-authors of Bo Pang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Pang. A scholar is included among the top collaborators of Bo Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Pang. Bo Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pang, Bo, Deyun Gao, Xianchao Zhang, et al.. (2025). FR-SFCO: Energy-Aware Offloading on Data Plane for Delay-Sensitive SFC. IEEE Transactions on Network and Service Management. 22(5). 3823–3837.
2.
Pang, Bo, et al.. (2024). Exploring the relations of NLR, hsCRP and MCP-1 with type 2 diabetic kidney disease: a cross-sectional study. Scientific Reports. 14(1). 3211–3211. 13 indexed citations
3.
Zhou, Zhemin, Yuan Zhang, Fangyu Ding, et al.. (2024). High carriage and possible hidden spread of multidrug-resistant Salmonella among asymptomatic workers in Yulin, China. Nature Communications. 15(1). 10238–10238. 5 indexed citations
4.
Duan, Qing, Yao Wang, Xiaolin Jiang, et al.. (2024). Spatial-temporal drivers and incidence heterogeneity of hemorrhagic fever with renal syndrome transmission in Shandong Province, China, 2016–2022. BMC Public Health. 24(1). 1032–1032. 2 indexed citations
5.
Pang, Bo, Lei Wu, & Ying Peng. (2024). In vitro modelling of the neurovascular unit for ischemic stroke research: Emphasis on human cell applications and 3D model design. Experimental Neurology. 381. 114942–114942. 8 indexed citations
6.
Wang, Xiaodong, et al.. (2024). Detection and phylogenetic classification of Neoehrlichia mikurensis in rodents from the region of Liupan Mountain, China. Frontiers in Microbiology. 15. 1409593–1409593. 1 indexed citations
7.
Xue, Mei, Qiong Wang, Bo Pang, et al.. (2023). Association Between Circulating Zinc and Risk for Childhood Asthma and Wheezing: A Meta-analysis on 21 Articles and 2205 Children. Biological Trace Element Research. 202(2). 442–453. 6 indexed citations
8.
Zhang, Yuwei, Shanshan Han, Shu Zhang, et al.. (2022). Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human. Frontiers in Immunology. 13. 1027180–1027180. 2 indexed citations
10.
Chen, Chao, Mingyan Zhang, Hui Wang, et al.. (2022). Development of a core outcome set on Traditional Chinese Medicine and Western Medicine for rheumatic heart disease: a study protocol. BMJ Open. 12(11). e062497–e062497. 3 indexed citations
11.
Zhang, Junhua, et al.. (2022). [Clinical evidence analysis report of Chinese patent medicine in 2020].. PubMed. 47(9). 2315–2321. 3 indexed citations
12.
Liu, Zhi, Nan Li, Yuyun Li, et al.. (2020). Chinese medical drugs for coronavirus disease 2019: a systematic review and meta-analysis. Integrative Medicine Research. 9(3). 100477–100477. 21 indexed citations
13.
Li, Nan, Wenke Zheng, Fengwen Yang, et al.. (2020). Evidence for the medicinal value of Squama Manitis (pangolin scale): A systematic review. Integrative Medicine Research. 10(1). 100486–100486. 12 indexed citations
14.
Zhang, Dong, Junhua Zhang, Nan Li, et al.. (2020). Tongue features of patients with coronavirus disease 2019: a retrospective cross-sectional study. Integrative Medicine Research. 9(3). 100493–100493. 28 indexed citations
16.
Wang, Lei, Ximing Wang, Shan Jiang, et al.. (2017). Role of Kidneys in Sex Differences in Angiotensin II–Induced Hypertension. Hypertension. 70(6). 1219–1227. 24 indexed citations
17.
Pang, Bo. (2009). Pathological Analysis of Diabetic Nephropathy with Micro-abdominal Mass. 1 indexed citations
18.
Rai, Priyamvada, Tamer T. Önder, Jennifer J. Young, et al.. (2008). Continuous elimination of oxidized nucleotides is necessary to prevent rapid onset of cellular senescence. Proceedings of the National Academy of Sciences. 106(1). 169–174. 145 indexed citations
19.
Meira, Lisiane B., James M. Bugni, Chung‐Wei Lee, et al.. (2008). DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. Journal of Clinical Investigation. 118(7). 2516–25. 436 indexed citations
20.
Pang, Bo, et al.. (2006). One-step generation of degraded DNA by UV irradiation. Analytical Biochemistry. 360(1). 163–165. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026